Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)
NCT ID: NCT04384419
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2020-05-29
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies by an on-line questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 and Psychotic Symptoms in France
NCT04356885
PSYCHIATRIC Disorders and Covid-19
NCT04358042
Evaluation of Metamemory in Patients With Schizophrenia
NCT03338179
Psychiatric Disturbances and COVID-19 Infection
NCT04459403
Past Pain Experience and Perception of Experimental Pain
NCT01575912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies.
Thus, using an online longitudinal questionnaire, the investigators wish to explore :
* how the memory system is impacted by mass deaths over several trimesters in the general population.
* whether the long-term memory of people suffering from depression and anxiety disorders and people suffering from schizotypal personality disorder contains recollection of a distorted pattern in relation to the actual number of deaths.
Primary goals of this project are:
Determine, in the context of mass deaths, the level and proportion of real or conceived recall of the number of deaths in the general population based on cognitive and affective empathy profiles over four trimesters.
Also the investigators want to determine
* the proportion of real or conceived recall numbers of deaths by COVID-19 among people suffering from depression and anxiety in a context of mass death.
* the proportion of real or conceived recall number of deaths by COVID-19 among people with schizotypal personality disorder.
* the dynamics of this real or conceived recall for four trimester following the end of lockdown.
Methodology:
The entire study will be conducted online. Participants will provide their informed consent. At these assessment, they will provide a set of self report measures associated to COVID-19 related psychological aspects especially for depression, anxiety and schizotypal personality.
Subjects can only participate once.
Sample size:
There is no minimum/maximum sample size for this study. The study will remain open for 1 year. The sample size should reach 1000 participants at least.
List of self-report measures:
* Brief Trauma Questionnaire (BTQ)
* COVID-Related Thoughts and Behavioral Symptoms (COV-TaBS)
* Beck Depression Inventory (BDI)
* State and Trait Anxiety Inventory (STAI)
* The Hospital Anxiety and Depression Scale (HAPS)
* Questionnaire of Cognitive and Affective Empathy (QCAE)
* Raine Schizotypal Personality Questionnaire, (SPQ)
* Paranoia Scale
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* French native speacker
* Majority 18 years and more
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Montpellier 3 (Pr. Stéphane Raffard, PhD)
UNKNOWN
University of Reims Champagne-Ardenne (Ali Oker PhD)
UNKNOWN
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphane Raffard, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals of Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL20_0276
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.